GUIDED THERAPEUTICS, INC. (GTHP) Net income 2016–2025
GUIDED THERAPEUTICS, INC. (GTHP) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$3.2MFY2025 · since FY2016: -$4.0M → -$3.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$3.2M | -32.2% |
| FY2024 | -$2.4M | +30.7% |
| FY2023 | -$3.5M | +19.6% |
| FY2022 | -$4.3M | -109.7% |
| FY2021 | -$2.1M | -641.9% |
| FY2020 | -$279,000 | +85.5% |
| FY2019 | -$1.9M | -289.1% |
| FY2018 | $1.0M | +109.5% |
| FY2017 | -$10.7M | -169.4% |
| FY2016 | -$4.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More GTHP financial trends
GTHP RevenueGTHP Net marginGTHP Gross profitGTHP Gross marginGTHP Operating incomeGTHP Operating marginGTHP Operating cash flowGTHP Free cash flowGTHP Capital expendituresGTHP Return on equityGTHP Stock buybacksGTHP Dividends paidGTHP Total assetsGTHP Total liabilitiesGTHP Shareholders’ equityGTHP overview →